Description of:Foretinib(GSK1363089)
GSK1363089 (XL880)is an orally bioavailable，small molecule MET/VEGFR2 inhibitor with potential antineoplastic activity. This compound binds to and selectively inhibits HGF receptor c-MET(IC50 of 0.4 nM)and VEGFR2, which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis.
Theoretical analysis:Foretinib(GSK1363089)
F M.Wt: 632.67
Formula: C34H34F2N4O6
Purity: >98%
Storage: at -20℃ 2 years
CAS No.: 849217-64-7
Solubility: DMSO
Availability and price:Foretinib(GSK1363089)
Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : sales@chemrenpharm.com
Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days
若要询价或订购，请打销售电话咨询：0519-85788828，或加QQ:2500035664咨询，量大从优,我们会尽快回复。
注意事项：仅于科学研究和实验室使用。
Antibody-drug Conjugate/ADC Related
Trk Receptor
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian